AI in Cardiology Market Size, Share & Trends Analysis Report By Type (Outpatient Scheduling, Inpatient Scheduling, Specialty Care Scheduling, Emergency & Urgent Care Scheduling, Others), By Deployment Mode (Cloud-based Deployment, On-premises Deployment), By End Use (Hospitals, Clinics, Diagnostic & Imaging Centers, Ambulatory Surgical Centers (ASCs), Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

AI in Cardiology Market Size

The global AI in cardiology market size was valued at USD 1.68 billion in 2025 and is projected to grow from USD 2.20 billion in 2026 to USD 19.30 billion by 2034, registering a CAGR of 31.16% during the forecast period from 2026 to 2034. North America dominated the AI in cardiology market with a market share of 47.68% in 2025.

Type Insights

The outpatient scheduling segment dominated the AI in cardiology market share in 2025 with a share of 43.45%, supported by high patient volumes in cardiology clinics, diagnostic facilities, and hospital outpatient departments. Cardiac consultants are increasingly relying on digital scheduling platforms to streamline tasks such as appointments, follow-ups, and preventive screening. There is a focus on long-term chronic disease management, minimizing delayed care, and updating healthcare infrastructure with the changing AI models. This change in healthcare operations is increasing the adoption of artificial intelligence-enabled outpatient scheduling systems. Thus, a shift toward proactive care with preventive healthcare management and data-driven clinical optimization is expected to boost the segment growth.

The specialty care scheduling segment is expected to record the fastest growth with a CAGR of 28.38%. A rising demand for coordinated scheduling across subspecialties such as interventional cardiology, electrophysiology, and heart failure management is expected to boost the segment growth. In this regard, artificial intelligence supports complex referral-based workflows and resource planning

Request Customizationto receive a tailored report.

Deployment Mode Insights

The cloud-based deployment segment dominated the AI in cardiology market in 2025 with a considerable share. This deployment method relies on scalability, centralized data access, and streamlined integration with hospital information systems and cardiology imaging platforms. It enables healthcare providers to manage large volumes of cardiac data, along with supporting remote access. This has increased the deployment of artificial intelligence updates throughout the healthcare infrastructure.

The on-premises deployment segment is projected to be the fastest growing with a CAGR of 28.78%. The segment growth is witnessed by the preference among large hospitals and healthcare networks for direct control over data security. It also assists in infrastructure customization and compliance with internal data governance policies in cardiology departments. This, in turn, boosts the AI in cardiology market growth during the forecast period.

End Use Insights

The hospitals segment held the dominant share of 43.34% in 2025, supported by high adoption of artificial intelligence across cardiology imaging, patient scheduling, and clinical decision support systems. Hospitals have robust integrated digital infrastructure and multidisciplinary cardiology services, which support a wide-scale deployment of artificial intelligence solutions.

The clinics segment is anticipated to grow at the fastest rate with a CAGR of 28.56%. Increasing digitization levels of standalone cardiology practices and outpatient clinics are expected to contribute to segment growth. These healthcare units are seeking artificial intelligence-enabled tools to manage patient flow, scheduling efficiency, and cardiac diagnostic workflows.

Speak to an Analystto discuss market opportunities.

Regional Analysis

The AI in cardiology market in North America held the largest share of 48.68% in the market in 2025 due to early adoption of AI-enabled cardiology software and widespread access to advanced diagnostic infrastructure across hospitals and cardiac imaging centers. The US Food and Drug Administration's organized clearance routes and robust interaction with enterprise imaging systems and clinical information platforms provide the region with a mature regulatory framework that facilitates the clinical adoption of AI-based cardiology solutions.

The US market shares the largest regional contribution due to the sustained investment in AI-based cardiology tools, federal-level digital health programs, and nationwide screening initiatives for cardiovascular disease. In January 2026, Cleerly disclosed on its official corporate website that Aetna expanded reimbursement coverage for its AI-based coronary plaque analysis platform, supporting broader clinical utilization of AI-driven cardiology imaging across the US.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific

Asia Pacific is emerging as a rapidly expanding region with a CAGR of 29.66% for AI in cardiology adoption, driven by large-scale hospital digitization programs and increasing installation of advanced cardiac imaging equipment. Countries across the region are investing in artificial intelligence-supported diagnostics to manage rising imaging volumes and the growing cardiovascular disease burden.

Leading Chinese medical technology firms have developed artificial intelligence-enabled cardiology imaging solutions that are becoming popular in clinical settings and complementing government-led hospital modernization and digital health initiatives. The recent introduction and implementation of an AI-powered cardiac ultrasound full-stack evaluation system by ࿈医疗 (Mindray), a Chinese medical device manufacturer, is a noteworthy example. This solution integrates AI into the entire cardiac ultrasound workflow to shorten scan times and simplify cardiac imaging procedures for clinicians. Features such as strain assessment and quantitative analysis across heart chambers support automated measurement of several cardiac parameters. The clinical potential and extended applications of this solution have improved cardiology imaging workflows. Innovations in line with procedures and imaging solutions are expected to position China as a leading country in the Asia Pacific market.

Europe

Europe continues to record strong adoption of AI in cardiology solutions. The region boasts of favorable policies that promote digital imaging interoperability and artificial intelligence integration within healthcare systems. Unified health data exchange frameworks across the European Union support cross-border access to cardiac imaging data, enabling wider deployment of AI-based cardiology tools within hospital networks.

Germany dominates the European market with its digital health initiatives. In November 2025, it hosted the ESC (European Society of Cardiology) Digital & AI Summit in Berlin, which focused on AI innovation across cardiovascular care. The country has a high installation density of advanced CT and MRI systems that support routine use of automated cardiac analysis software in clinical diagnostics. The country has well-established players in this market who focus on advancing imaging solutions. For instance, in November 2025, Siemens Healthineers introduced its new integrated imaging suite powered by artificial intelligence named Optiq AI, designed to enhance image quality and workflow for interventional procedures that include cardiology applications.

Latin America

Latin America demonstrates a steady growth in the AI in cardiology market, with an expanding base of digital imaging infrastructure and regional health informatics initiatives. The region is focusing on standardizing electronic clinical records and diagnostic imaging workflows to improve readiness for the adoption of AI in cardiology.

Brazil leads the Latin American region through public sector digitization of primary and secondary healthcare systems, enabling integration of cardiac imaging analytics into broader diagnostic pathways. The Ministry of Health, with its SUS Digital initiative, focuses on integrating electronic health records (EHRs) across the public health system and boosting telehealth services. The country is moving toward standardizing digital data exchange across multiple healthcare end users.

Middle East and Africa

The Middle East and Africa market has government-backed digital health transformation programs and increased investment in advanced diagnostic technologies. National health information platforms and secure data exchange initiatives are improving access to cardiac imaging data. For instance, Unified Medical Records by the UAE is a national unified health record platform for standardized health records for public and private providers. Vision 2030 of Saudi Arabia focuses on driving digital healthcare data for improved AI-augmented diagnosis.

South Africa leads the regional market with its modernization efforts for cardiology and radiology departments across public hospital networks. A Philips Future Health Index 2025 report indicated that 91% of healthcare professionals in the country believe AI can reduce hospital admissions. Health reforms such as National Health Insurance encourage higher technology adoption for improved service to patients, leading to AI integration in existing infrastructure. The country has a clinical environment already comfortable using digital technology, which is expected to maintain its leading position in the market in the coming years.

Regulatory Bodies Governing AI in Cardiology Market

Competitive Landscape

The AI in cardiology market is moderately fragmented with competition among multinational medical imaging companies, healthcare IT providers, specialized artificial intelligence developers, and regional digital health firms. Established players compete on factors such as a broad product portfolio and scalability potential. Regional and smaller players focus more on pricing agility, customization, and alignment with local clinical workflows. The intensity of competition is governed by technology differentiation, algorithm performance, clinical evidence, regulatory approvals, geographic reach, and reimbursement models. Emerging trends include longitudinal cardiac intelligence platforms, multimodal data integration, workflow automation across imaging modalities, expansion into outpatient cardiology settings, and partnerships between imaging hardware manufacturers and artificial intelligence software providers.

List of Key and Emerging Players in AI in Cardiology Market